Capgemini and MammaCare® Combine Intelligent Technologies to Improve Breast Cancer Screening

Mon Oct 21, 2013 8:30am EDT

* Reuters is not responsible for the content in this press release.

Capgemini and MammaCare® Combine Intelligent Technologies to Improve Breast Cancer Screening

Capgemini, one of the world’s foremost providers of consulting, technology and outsourcing services, is proud to announce a partnership with MammaCare®, the recognized quality-standard for physical examination of the breast, developed with the support of the National Cancer Institute, the National Science Foundation and medical scientists worldwide.

Breast cancer screening will be more accurate because science and technology teams from MammaCare and Capgemini are working together to advance clinical breast exam competencies. Millions of clinical breast exams are performed annually but the common practice is cursory and erratic. The National Science Foundation supported development of MammaCare’s new training technology that standardizes the performance of clinical breast exams, significantly improving their accuracy and thoroughness. Laboratory and clinical studies demonstrated the effectiveness of the technology.

The leap from laboratory to clinical classrooms happened when Capgemini’s Strategic Technologies and Applications Team (STAT) offered their assistance. The Capgemini team launched the system into the cloud on their Cloud Orchstration Management PLatform End to End or “COMPLETE”, powered by Amazon Web Services (AWS). This enabled global reach, making it accessible to all colleges of nursing and medicine and practicing clinicians. The Capgemini and AWS infrastructure is elastic, expanding automatically with demand, and eliminating the need for MammaCare to maintain any IT infrastructure.

The engineering and scientific expertise of each team was essential in creating, validating and increasing the reach of MammaCare’s skill-based technology according to Dr. Mary Ann Mehn, MammaCare’s Director of Education. “Now, all students and clinicians can rapidly acquire the skills needed to perform competent, quality-standard breast exams,” she added.

Mark Kane Goldstein PhD, MammaCare’s Chairman and Senior Scientist, observed, “When top technology teams from different disciplines work together on a common problem, the results can be amazing.”

Joe Coyle, North America Chief Technology Officer for Capgemini, stated, “We at Capgemini are driven to change the way we offer cutting edge technology to the business world. By partnering with MammaCare on such a globally important cause, we are able to participate in a higher goal with a human touch. This is why we are so proud to support MammaCare in helping women across North America.”

For more information on MammaCare, please visit www.mammacare.com. Also, please view a video produced by the National Science Foundation where Mark Kane Goldstein PhD discusses and demonstrates MammaCare, the revolutionary tool that has set standards for teaching women and technicians how to perform clinical breast exams.

About Capgemini

With more than 125,000 people in 44 countries, Capgemini (www.capgemini.com) is one of the world's foremost providers of consulting, technology and outsourcing services. The Group reported 2012 global revenues of EUR 10.3 billion (more than $13 billion USD). Together with its clients, Capgemini creates and delivers business and technology solutions that fit their needs and drive the results they want. A deeply multicultural organization, Capgemini has developed its own way of working, the Collaborative Business ExperienceTM, and draws on Rightshore®, its worldwide delivery model.

Rightshore® is a trademark belonging to Capgemini.

Press:
Capgemini
Tara Marion, +1 469-878-8384
tara.marion@capgemini.com